Yamil Ballestas-Casallas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yamil Ballestas-Casallas has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Danilo Lusbin Ariza Rua
Faculty of Basic Sciences Technological University of Bolivar Cartagena de Indias-Bolívar, Colombia
1 shared publication - Edisson Chavarro-Mesa
Dirección de Ciencias Básicas Universidad Tecnológica de Bolívar Cartagena de Indias-Colombia
1 shared publication - Juan Rebollo-Perez
Faculty of Basic Sciences Technological University of Bolivar Cartagena de Indias-Bolívar, Colombia
1 shared publication - Wilson Maldonado-Rojas
School of Pharmaceutical Sciences, University of Cartagena Cartagena de Indias-Bolívar, Colombia
1 shared publication
Latest Publications
- Open Access
- 1 January 2023
- Published by AIP Publishing in AIP Conference Proceedings
- Vol. 2872 (1)
Molecular docking studies of 4-nitromonosubstituted chalcone derivatives as cyclooxygenase-2 (COX-2) inhibitors
A series of 4-nitrochalcone derivatives was designed and docked into the crystal structures of the cyclooxygenase-2 (COX-2) enzyme to calculate the binding affinity of each derivative within the protein active site. We employed the non-selective COX-2 inhibitor ibuprofen and the selective COX-2 inhibitor celecoxib as references to compare the interaction and likely inhibitory impact of the 4-nitrochalcone derivatives. Ibuprofen showed lower affinity values than 3’-COOH-4-nitrochalcone, 3’-CF3-4-nitrochalcone and 3’-NO2-4-nitrochalcone. These derivatives act in the same way as celecoxib at the active site of COX-2. This information could be useful in the development of monosubstituted 4-nitrochalcone derivatives as anti-inflammatory compounds.
- 1 January 2023
- Published by AIP Publishing in AIP Conference Proceedings
- Vol. 2872 (1)
Open AccessMolecular docking studies of 4-nitromonosubstituted chalcone derivatives as cyclooxygenase-2 (COX-2) inhibitors
A series of 4-nitrochalcone derivatives was designed and docked into the crystal structures of the cyclooxygenase-2 (COX-2) enzyme to calculate the binding affinity of each derivative within the protein active site. We employed the non-selective COX-2 inhibitor ibuprofen and the selective COX-2 inhibitor celecoxib as references to compare the interaction and likely inhibitory impact of the 4-nitrochalcone derivatives. Ibuprofen showed lower affinity values than 3’-COOH-4-nitrochalcone, 3’-CF3-4-nitrochalcone and 3’-NO2-4-nitrochalcone. These derivatives act in the same way as celecoxib at the active site of COX-2. This information could be useful in the development of monosubstituted 4-nitrochalcone derivatives as anti-inflammatory compounds.